Literature DB >> 6687418

Evaluation of hemostatic agents in experimental splenic lacerations.

D Coln, J Horton, M E Ogden, L M Buja.   

Abstract

Avitene, Collastat, Gelfoam, and Surgicel were evaluated for their effectiveness in the control of hemorrhage from an experimental splenic laceration. Effectiveness was determined by measuring the amount of blood loss per kilogram of body weight until complete hemostasis was achieved and by determining mortality from hemorrhage. The study group in which Collastat, a collagen hemostatic sponge, was used had the smallest amount of blood loss. This group was also the only one with no deaths from breakthrough bleeding. The degrees of reaction in the spleens of the surviving animals 3 weeks after treatment were not significantly different when each of the various agents were compared. We believe that Collastat is the preferred topical hemostatic agent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687418     DOI: 10.1016/0002-9610(83)90074-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Conservative surgery for benign non-parasitic splenic cysts.

Authors:  A J Holland; W D Ford; A J Bourne
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

2.  Surgery of the traumatized spleen.

Authors:  F S Bongard; R C Lim
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

3.  Videolaparoscopic treatment of spleen injuries. Report of two cases.

Authors:  A Tricarico; A Tartaglia; F Taddeo; R Sessa; E Sessa; S Minelli
Journal:  Surg Endosc       Date:  1994-08       Impact factor: 4.584

4.  Splenorrhaphy. The alternative.

Authors:  D V Feliciano; V Spjut-Patrinely; J M Burch; K L Mattox; C G Bitondo; P Cruse-Martocci; G L Jordan
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

5.  Hemostatic properties of a venomic protein in rat organ trauma.

Authors:  Roscoe L Warner; Shannon D McClintock; Adam G Barron; Felix A de la Iglesia
Journal:  Exp Mol Pathol       Date:  2009-09-10       Impact factor: 3.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.